Structural Disorganization of Intestinal Tumor Spheroid by Microbial Ribotoxins |
Kim, Juil
(Laboratory of Mucosal Exposome and Biomodulation, Department of Biomedical Sciences, BioMedical Research Institute, Pusan National University)
Kim, Joongkon (Laboratory of Mucosal Exposome and Biomodulation, Department of Biomedical Sciences, BioMedical Research Institute, Pusan National University) Yu, Mira (Laboratory of Mucosal Exposome and Biomodulation, Department of Biomedical Sciences, BioMedical Research Institute, Pusan National University) Moon, Yuseok (Laboratory of Mucosal Exposome and Biomodulation, Department of Biomedical Sciences, BioMedical Research Institute, Pusan National University) |
1 | Ong CW, Kim LG, Kong HH, Low LY, Iacopetta B, Soong R, et al. 2010. CD133 expression predicts for non-response to chemotherapy in colorectal cancer. Mod. Pathol. 23: 450-457. DOI |
2 | Du L, Wang H, He L, Zhang J, Ni B, Wang X, et al. 2008. CD44 is of functional importance for colorectal cancer stem cells. Clin. Cancer Res. 14: 6751-6760. DOI |
3 | Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, et al. 2009. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69: 3382-3389. DOI |
4 | Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. 2007. Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115. DOI |
5 | Moon Y. 2011. Mucosal Injuries due to Ribosome-Inactivating Stress and the Compensatory Responses of the Intestinal Epithelial Barrier. Toxins 3: 1263-1277. DOI |
6 | Maresca M, Fantini J. 2010. Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. Toxicon 56: 282-294. DOI |
7 | Mishra S, Tewari P, Chaudhari BP, Dwivedi PD, Pandey HP, Das M. 2016. Deoxynivalenol induced mouse skin tumor initiation: Elucidation of molecular mechanisms in human HaCaT keratinocytes. Int. J. Cancer. 139: 2033-2046. DOI |
8 | Graziani F, Pujol A, Nicoletti C, Pinton P, Armand L, Di Pasquale E, et al. 2015. The food-associated ribotoxin deoxynivalenol modulates inducible NO synthase in human intestinal cell model. Toxicol. Sci. 145: 372-382. DOI |
9 | Yoder JM, Aslam RU, Mantis NJ. 2007. Evidence for widespread epithelial damage and coincident production of monocyte chemotactic protein 1 in a murine model of intestinal ricin intoxication. Infect. Immun. 75: 1745-1750. DOI |
10 | Islam Z, Gray JS, Pestka JJ. 2006. p38 Mitogen-activated protein kinase mediates IL-8 induction by the ribotoxin deoxynivalenol in human monocytes. Toxicol. Appl. Pharmacol. 213: 235-244. DOI |
11 | Iordanov MS, Pribnow D, Magun JL, Dinh TH, Pearson JA, Chen SL, et al. 1997. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol. Cell Biol. 17: 3373-3381. DOI |
12 | Shifrin VI, Anderson P. 1999. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J. Biol. Chem. 274: 13985-13992. DOI |
13 | Park SH, Choi HJ, Yang H, Do KH, Kim J, Moon Y. 2010. Repression of peroxisome proliferator-activated receptor gamma by mucosal ribotoxic insult-activated CCAAT/enhancer-binding protein homologous protein. J. Immunol. 185: 5522-5530. DOI |
14 | Edmondson R, Broglie JJ, Adcock AF, Yang L. 2014. Threedimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev. Technol. 12: 207-218. DOI |
15 | Zhou HR, Lau AS, Pestka JJ. 2003. Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenolinduced ribotoxic stress response. Toxicol. Sci. 74: 335-344. DOI |
16 | Laskin JD, Heck DE, Laskin DL. 2002. The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity. Toxicol. Sci. 69: 289-291. DOI |
17 | Birgersdotter A, Sandberg R, Ernberg I. 2005. Gene expression perturbation in vitro--a growing case for three-dimensional (3D) culture systems. Semin. Cancer Biol. 15: 405-412. |
18 | Kim JB. 2005. Three-dimensional tissue culture models in cancer biology. Semin. Cancer Biol. 15: 365-377. |
19 | Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. 2006. Epidemiology and management of liver metastases from colorectal cancer. Ann. Surg. 244: 254-259. DOI |
20 | Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. 2004. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32. DOI |
21 | Jin K, Gao W, Lu Y, Lan H, Teng L, Cao F. 2012. Mechanisms regulating colorectal cancer cell metastasis into liver (Review). Oncol. Lett. 3: 11-15. DOI |
22 | O'Brien CA, Pollett A, Gallinger S, Dick JE. 2007. A human colon cancer cell capable of initiating tumour growth in immunode-ficient mice. Nature 445: 106-110. DOI |
23 | Cho RW, Clarke MF. 2008. Recent advances in cancer stem cells. Curr. Opin. Genet. Dev. 18: 48-53. DOI |
24 | Abdullah LN, Chow EK. 2013. Mechanisms of chemoresistance in cancer stem cells. Clin. Transl. Med. 2: 3. DOI |
25 | Kozovska Z, Gabrisova V, Kucerova L. 2014. Colon cancer: cancer stem cells markers, drug resistance and treatment. Biomed. Pharmacother. 68: 911-916. DOI |
26 | Oh CK, Lee SJ, Park SH, Moon Y. 2016. Acquisition of chemoresistance and other malignancy-related features of colorectal cancer cells are incremented by Ribosome-inactivating stress. J. Biol. Chem. 291: 10173-10183. DOI |
27 | Choi HJ, Kim J, Do KH, Park SH, Moon Y. 2013. Prolonged NF-kappaB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells. Infect. Immun. 81: 1860-1869. DOI |
28 | Fluckiger A, Dumont A, Derangere V, Rebe C, de Rosny C, Causse S, et al. 2016. Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNF . Oncogene 35: 4611-4622. DOI |
29 | Howard A, Tahir I, Javed S, Waring SM, Ford D, Hirst BH. 2010. Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage. J. Physiol. 588: 995-1009. DOI |